[Genetic factors in myocardial infarction]

Area of Science:

• Cardiovascular Genetics
• Genomics
• Molecular Medicine

Background:

• Acute myocardial infarction (AMI) involves coronary artery occlusion due to plaque rupture and thrombus formation.
• Risk factors include hypertension, diabetes, dyslipidemia, smoking, obesity, and family history, suggesting gene-environment interactions.
• Genetic susceptibilities play a crucial role in AMI development.

Purpose of the Study:

• To review the methodology of genome-wide association studies (GWAS).
• To introduce genetic variants identified by GWAS that confer susceptibility to AMI.
• To discuss the future potential of GWAS in understanding AMI genetic susceptibility.

Main Methods:

• Genome-wide association studies (GWAS) examine common genetic variants (e.g., single-nucleotide polymorphisms or SNPs) for association with traits in a case-control manner.
• Focus on identifying robust susceptibility variants, such as the SNP on chromosome 9p21, for AMI.

Main Results:

• GWAS have identified significant genetic variants associated with AMI risk.
• The single-nucleotide polymorphism (SNP) on chromosome 9p21 is a well-established genetic susceptibility factor for AMI.
• Numerous new genetic susceptibilities for AMI have been uncovered through GWAS.

Conclusions:

• GWAS are powerful tools for discovering genetic factors contributing to complex diseases like AMI.
• Understanding these genetic susceptibilities is vital for advancing AMI research and prevention strategies.
• Future applications of GWAS hold promise for further elucidating the genetic architecture of AMI.